Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study
- PMID: 22895826
- PMCID: PMC7079899
- DOI: 10.1007/s00134-012-2673-2
Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study
Abstract
Purpose: Despite their controversial role, corticosteroids (CS) are frequently administered to patients with H1N1 virus infection with severe respiratory failure secondary to viral pneumonia. We hypothesized that invasive pulmonary aspergillosis (IPA) is a frequent complication in critically ill patients with H1N1 virus infection and that CS may contribute to this complication.
Methods: We retrospectively selected all adult patients with confirmed H1N1 virus infection admitted to the intensive care unit (ICU) of two tertiary care hospitals from September 2009 to March 2011. Differences in baseline factors, risk factors, and outcome parameters were studied between patients with and without IPA.
Results: Of 40 critically ill patients with confirmed H1N1, 9 (23 %) developed IPA 3 days after ICU admission. Five patients had proven and four had probable IPA. Significantly more IPA patients received CS within 7 days before ICU admission (78 versus 23 %, p = 0.002). IPA patients also received significantly higher doses of CS before ICU admission [hydrocortisone equivalent 800 (360-2,635) versus 0 (0-0) mg, p = 0.005]. On multivariate analysis, use of CS before ICU admission was independently associated with IPA [odds ratio (OR) 14.4 (2.0-101.6), p = 0.007].
Conclusions: IPA was diagnosed in 23 % of critically ill patients with H1N1 virus infection after a median of 3 days after ICU admission. Our data suggest that use of CS 7 days before ICU admission is an independent risk factor for fungal superinfection. These findings may have consequences for clinical practice as they point out the need for increased awareness of IPA, especially in those critically ill H1N1 patients already receiving CS.
Figures

Comment in
-
Invasive pulmonary aspergillosis in the ICU: an emerging disease?Intensive Care Med. 2013 Apr;39(4):790. doi: 10.1007/s00134-012-2809-4. Epub 2013 Jan 22. Intensive Care Med. 2013. PMID: 23338571 No abstract available.
-
Invasive pulmonary aspergillosis in the ICU: reply to Wichmann et al.Intensive Care Med. 2013 Apr;39(4):791. doi: 10.1007/s00134-012-2810-y. Epub 2013 Jan 22. Intensive Care Med. 2013. PMID: 23338572 No abstract available.
Similar articles
-
Invasive pulmonary aspergillosis in the ICU: reply to Wichmann et al.Intensive Care Med. 2013 Apr;39(4):791. doi: 10.1007/s00134-012-2810-y. Epub 2013 Jan 22. Intensive Care Med. 2013. PMID: 23338572 No abstract available.
-
Invasive pulmonary aspergillosis in the ICU: an emerging disease?Intensive Care Med. 2013 Apr;39(4):790. doi: 10.1007/s00134-012-2809-4. Epub 2013 Jan 22. Intensive Care Med. 2013. PMID: 23338571 No abstract available.
-
Overtreating or underdiagnosing invasive pulmonary aspergillosis (IPA) in critically ill H1N1 patients: who is right?Intensive Care Med. 2012 Nov;38(11):1733-5. doi: 10.1007/s00134-012-2677-y. Epub 2012 Aug 16. Intensive Care Med. 2012. PMID: 22895827 No abstract available.
-
Invasive pulmonary aspergillosis in patients with influenza infection: A retrospective study and review of the literature.Clin Respir J. 2019 Apr;13(4):202-211. doi: 10.1111/crj.12995. Epub 2019 Mar 18. Clin Respir J. 2019. PMID: 30661296 Review.
-
Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment.Curr Opin Infect Dis. 2018 Dec;31(6):471-480. doi: 10.1097/QCO.0000000000000504. Curr Opin Infect Dis. 2018. PMID: 30299367 Review.
Cited by
-
Invasive pulmonary aspergillosis in the ICU: reply to Wichmann et al.Intensive Care Med. 2013 Apr;39(4):791. doi: 10.1007/s00134-012-2810-y. Epub 2013 Jan 22. Intensive Care Med. 2013. PMID: 23338572 No abstract available.
-
Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?Pharmaceutics. 2022 Dec 3;14(12):2707. doi: 10.3390/pharmaceutics14122707. Pharmaceutics. 2022. PMID: 36559201 Free PMC article. Review.
-
Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU-Practical Recommendations from an Expert Group for CAPA/IAPA Patients.J Fungi (Basel). 2023 Mar 2;9(3):312. doi: 10.3390/jof9030312. J Fungi (Basel). 2023. PMID: 36983480 Free PMC article.
-
IFN Receptor 2 Regulates TNF-α-Mediated Damaging Inflammation during Aspergillus Pulmonary Infection.J Immunol. 2024 Oct 15;213(8):1202-1211. doi: 10.4049/jimmunol.2200686. J Immunol. 2024. PMID: 39212415
-
Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets.Diagnostics (Basel). 2022 Jun 1;12(6):1364. doi: 10.3390/diagnostics12061364. Diagnostics (Basel). 2022. PMID: 35741174 Free PMC article. Review.
References
-
- Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009, Influenza Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708–1719. doi: 10.1056/NEJMra1000449. - DOI - PubMed
-
- Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ. 2008;336:1006–1009. doi: 10.1136/bmj.39537.939039.BE. - DOI - PMC - PubMed
-
- Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, Martinez MA, Rivero E, Valdez R, Ruiz-Palacios G, Hernández M, Stewart TE, Fowler RA. Critically Ill patients with 2009 influenza A (H1N1) in Mexico. JAMA. 2009;302:1880–1887. doi: 10.1001/jama.2009.1536. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical